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Introduction {#pim12291-sec-0001}
============

*Taenia solium* is a cestode parasite transmitted between humans acting as definitive hosts and pigs as intermediate hosts. The medical significance of the parasite arises not from it causing taeniasis but because humans may become infected with the larval or metacestode life cycle stage, in which case it commonly encysts in the brain and spinal cord, causing neurocysticercosis.

Neurocysticercosis is a major cause of neurological disease in many developing countries [1](#pim12291-bib-0001){ref-type="ref"}, [2](#pim12291-bib-0002){ref-type="ref"} and an increasing cause of disease in the developed world due to migration of presymptomatic neurocysticercosis patients [3](#pim12291-bib-0003){ref-type="ref"}, [4](#pim12291-bib-0004){ref-type="ref"}. In endemic areas, neurocysticercosis is considered to be the most frequent preventable cause of seizure disorders, being associated with 29% of people with epilepsy [5](#pim12291-bib-0005){ref-type="ref"}. *T. solium* is ranked as the most important foodborne parasitic infection from a global perspective [6](#pim12291-bib-0006){ref-type="ref"}. The World Health Organization added infections with *T. solium* to the list of Neglected Tropical Diseases in 2010 and continues to actively promote the development and implementation of strategies to decrease the incidence of neurocysticercosis [7](#pim12291-bib-0007){ref-type="ref"}.

The full lifecycle of *T. solium* is only perpetuated where pigs eat human faeces, or eat items contaminated by human faeces. For this reason, full transmission of the parasite from humans to pigs and back to humans occurs where sanitation is poor, meat inspection is limited or missing, awareness is low and facilities for safe preparation of food are inadequate. These conditions are reflected in poor, neglected populations; there is no demand for control of the parasite\'s full transmission cycle in developed countries. This places a considerable constraint on the methods that would be feasible or sustainable to achieve control of the parasite\'s transmission.

Consideration of the life cycle of *T. solium* immediately identifies several potential opportunities where parasite transmission could be interrupted: treatment of human taeniasis carriers to remove adult tapeworms, education of the population about personal hygiene to prevent human‐to‐human transmission and safe disposal of human faeces, preventing pigs gaining access to human faeces or items contaminated with faeces, meat inspection and removal of contaminated meat from the food chain, treatment of pigs to kill muscle cysticerci or vaccination of pigs to prevent the establishment of cysticerci. Several experimental trials have been undertaken to control *T. solium* transmission by implementing one or a combination of these strategies [8](#pim12291-bib-0008){ref-type="ref"}, [9](#pim12291-bib-0009){ref-type="ref"}. Results of these trials have been variable; however, to this time, there are few examples where a substantial level of control has been achieved and has endured.

Three relatively new tools are available to assist in the control of *T. solium* -- coproantigen testing for taeniasis [10](#pim12291-bib-0010){ref-type="ref"}, treatment of pigs with oxfendazole to kill cysticerci [11](#pim12291-bib-0011){ref-type="ref"} and the TSOL18 vaccine for pigs to prevent *T. solium* infection [12](#pim12291-bib-0012){ref-type="ref"}, [13](#pim12291-bib-0013){ref-type="ref"}, [14](#pim12291-bib-0014){ref-type="ref"}. There is an increasing interest in implementing a One Health approach to human and animal diseases, and this applies most obviously to zoonotic infections such as *T. solium*. A growing awareness of the need to evaluate existing strategies to control *T. solium* is stimulating new initiatives to evaluate intervention options that span different sectors.

An obvious and important aspect of any intervention against *T. solium* is an evaluation of the outcomes of control initiatives. Not so obvious is which outcomes can or should be measured. The overall objective of *T. solium* control is to reduce the incidence of human cysticercosis. Other, indirect measures that would reflect changes in *T. solium* transmission are the incidence of human taeniasis due to *T. solium* or the incidence of porcine cysticercosis, changes in which could be expected to affect, directly or indirectly, the risk for new cases of cysticercosis in humans. Each of these different aspects of the *T. solium* life cycle can be assessed by a variety of techniques. Currently, there is no consensus about which *T. solium* assessment measures would be most suitable or effective for evaluating cysticercosis control initiatives. One of the most important attributes of any measure that is used to assess *T. solium* control efforts is specificity. Evaluation methods that have poor specificity for *T. solium* risk a misinterpretation of the outcomes of control activities because each false positive in a test would imply a control failure. Some tests for *T. solium* infection are either known to have poor specificity or they have been inadequately assessed in this respect. Another vital factor that affects the choice of assessment measures is their availability, particularly in endemic countries, and the feasibility of tests due to cost or technical complexity.

In the following review, we undertake a critical assessment of the tests that are potentially available to monitor and evaluate the outcomes of *T. solium* control. The review is not intended to be comprehensive, rather it focuses on assessment methods that have been, or are being used to monitor *T. solium* interventions, and those supported by verified data. Nor is it intended to evaluate the diagnostic tests used for the individual human patient. Comments are made about what are considered to be the most urgent research or development requirements needed to improve the effectiveness or availability of *T. solium* assessment tools and evidence‐based suggestions are made about which tests should be used to monitor *T. solium* interventions, based on current knowledge.

Human Cysticercosis/Neurocysticercosis {#pim12291-sec-0002}
======================================

Untreated cases of *T. solium* cysticercosis in humans may endure for many years, and for this reason, the prevalence of human cysticercosis would not be an appropriate measure to evaluate the outcomes of anything other than long‐term interventions. Assessment of changes in the incidence of cysticercosis in the human population would be meaningful, but only if control measures were being implemented so as to affect a sufficiently large population to allow significant changes to be detected, and over a sufficient interval of time. Until now, those interventions for *T. solium* that have attempted to assess changes in the level of human infections have used serological methods or questionnaires that were not necessarily able to confirm infection *per se*. In a clinical setting, neurocysticercosis is diagnosed using a combination of imaging techniques together with serology for confirmation [15](#pim12291-bib-0015){ref-type="ref"}. Sufficient resources are unlikely to be available to use imaging for the detection of neurocysticercosis on a population basis, other than possibly in exceptional circumstances.

Antibody detection tests {#pim12291-sec-0003}
------------------------

Several serological tests have been developed for the detection of the presence of anti‐*T. solium* antibodies induced by cysticercosis in humans and are considered to have a high level of specificity [16](#pim12291-bib-0016){ref-type="ref"}. Parkhouse and Harrison [17](#pim12291-bib-0017){ref-type="ref"} applied lentil lectin affinity chromatography for the identification of *T. solium* cysticercus glycoprotein antigens recognized by patients with cysticercosis. Tsang *et al*. [18](#pim12291-bib-0018){ref-type="ref"} utilized similar methods in a Western immunoblot assay (designated enzyme‐linked immunoelectrotransfer blot or EITB) and developed a method considered by the authors to have absolute specificity for *T. solium* [16](#pim12291-bib-0016){ref-type="ref"}, [18](#pim12291-bib-0018){ref-type="ref"}. The antigens recognized in the test have been characterized and produced as synthetic or recombinant proteins [19](#pim12291-bib-0019){ref-type="ref"}. Attempts to date to convert the test from a Western blot assay to an ELISA format have not resulted in sensitivity/specificity outcomes comparable with that achieved using native antigens [20](#pim12291-bib-0020){ref-type="ref"}, [21](#pim12291-bib-0021){ref-type="ref"}. Ito *et al*. [22](#pim12291-bib-0022){ref-type="ref"} developed an ELISA‐based assay using cysticercus antigens purified by preparative isoelectric‐focusing. The test shows a high sensitivity and specificity for diagnosis of human cysticercosis but has not been widely adopted, possibly because of the resources required to prepare the antigen.

Several serological tests for human cysticercosis are widely available as commercial products. Some manufacturers of ELISA kits mention limitations due to cross‐reactions with *Echinococcus*. Prices vary widely, from US\$ 5 to 30 per test depending on the manufacturer and the supplier. Tests based on Western blots (EITB) are available commercially but the price is even higher (up to US\$ 347/sample for the test provided by one company). Tests for *T. solium*‐specific antibodies do not differentiate viable from nonviable infections.

Garcia *et al*. [23](#pim12291-bib-0023){ref-type="ref"} undertook a longitudinal study of the serological reactivity to *T. solium* in people living in three different disease‐endemic areas of Peru and Colombia. The study revealed that many people display transient but unequivocally positive reactions in anti‐*T. solium* antibody detection tests, in the absence of any other evidence to suggest that the people harboured detectable cysticerci. These reactions may have been due to exposure to *T. solium* (eggs) that did not lead to the establishment of a continuing, detectable infection with cysticerci. This interpretation is supported by substantial evidence indicating that the EITB shows very high specificity for *T. solium* [16](#pim12291-bib-0016){ref-type="ref"}, [18](#pim12291-bib-0018){ref-type="ref"}. The transient nature of some serological responses to cysticercosis antigens was confirmed by Meza‐Lucas *et al*. [24](#pim12291-bib-0024){ref-type="ref"} in Mexico and more recently using EITB with sera from residents in an endemic region of Zambia [25](#pim12291-bib-0025){ref-type="ref"}. However, there is no direct evidence to support an association between *T. solium* exposure in humans and transient positive reactions in EITB. In pigs, cross‐reactions were found in *T. solium* EITB when sera were tested from specific pathogen free animals that had been exposed to *Taenia asiatica* [26](#pim12291-bib-0026){ref-type="ref"}, highlighting the potential for false‐positive reactions possibly occurring in humans exposed to *Taenia* sp. other than *T. solium*. Further evidence is needed to confirm that transient positive reactions in anti‐*T. solium* antibody detection tests are uniquely associated with exposure to *T. solium*.

Antigen detection tests {#pim12291-sec-0004}
-----------------------

Several serological tests have been developed which detect circulating *T. solium* cyst antigens in humans [16](#pim12291-bib-0016){ref-type="ref"}. The two most commonly evaluated tests were both originally developed to detect infection with *Taenia saginata* in cattle [27](#pim12291-bib-0027){ref-type="ref"}, [28](#pim12291-bib-0028){ref-type="ref"}, [29](#pim12291-bib-0029){ref-type="ref"}, and both were subsequently found to detect *T. solium* cysticercosis in pigs [30](#pim12291-bib-0030){ref-type="ref"}, [31](#pim12291-bib-0031){ref-type="ref"} and humans [32](#pim12291-bib-0032){ref-type="ref"}, [33](#pim12291-bib-0033){ref-type="ref"}. One antigen ELISA for *T. solium* is available commercially (apDia, Belgium); the current cost of the test (€145 per kit, duplicate testing, cost €3·15/sample) would be a significant disincentive to its use on a population‐wide basis. Patient\'s sera are only positive in *T. solium* antigen ELISA in cases where there is infection with viable *T. solium* cysticerci [32](#pim12291-bib-0032){ref-type="ref"}, [33](#pim12291-bib-0033){ref-type="ref"}. Antigen ELISA has been described as being sensitive for *T. solium* infections in humans where there are ≥2 viable cysts [34](#pim12291-bib-0034){ref-type="ref"}; little information is available about the performance of the commercially available test. Analysis of sera from humans with parasitic infections, or conditions other than *T. solium* infection, indicates the test is highly specific for *T. solium* [16](#pim12291-bib-0016){ref-type="ref"}, [33](#pim12291-bib-0033){ref-type="ref"}.

Two recent studies undertaken in Zambia [25](#pim12291-bib-0025){ref-type="ref"} and Ecuador [35](#pim12291-bib-0035){ref-type="ref"} have revealed that many antigen ELISA‐positive patients among people living in areas that are endemic for transmission of *T. solium* have only transient positive reactions and are likely to revert to being seronegative. These responses may have been due to infections that never fully establish but led to transient antibody responses and the short‐term presence of circulating antigen. However, as discussed above in relation to antibody detection tests, there is no direct evidence to support this view. The communities in Zambia [25](#pim12291-bib-0025){ref-type="ref"} and Ecuador [35](#pim12291-bib-0035){ref-type="ref"} where longitudinal studies were undertaken using antigen ELISA would be likely to have been endemic for transmission of several taeniid cestode parasites involving humans, dogs or other carnivores as definitive hosts, not just *T. solium*. There is potential for exposure of humans to the eggs of a number of these species, any of which could possibly cause a transient immunological response detected in the *T. solium* antigen ELISA. It is known that infection with either *Taenia hydatigena* [36](#pim12291-bib-0036){ref-type="ref"} or *T. asiatica* (a parasite most closely related to *T. saginata*) [37](#pim12291-bib-0037){ref-type="ref"} in pigs leads to persistent strong positive reactions in the same *T. solium* antigen ELISA. Transient positive responses in the *T. solium* antigen ELISA in humans could possibly be due to exposure to eggs of *T. hydatigena* or *T. saginata,* or of other taeniid cestode species, that did not lead to actual infections.

Research/development needs {#pim12291-sec-0005}
--------------------------

Additional evidence is needed to determine whether transient positive responses seen in anti‐*T. solium* antibody or serum antigen tests in people living in endemic areas are due to exposure to *T. solium* eggs.Refinement of both the EITB and antigen ELISA methodology to provide simpler and less expensive procedures.

*Taenia Solium* Taeniasis {#pim12291-sec-0006}
=========================

It seems intuitively obvious that monitoring of *T. solium* taeniasis would be of value for assessing the outcomes of *T. solium* control activities; human taeniasis is the sole source of human cysticercosis. A decline in, or absence of, *T. solium* taeniasis would be reflected in a reduced risk of new cases of cysticercosis. However, whether it would be meaningful and valuable to invest resources in diagnosis of taeniasis would depend on the prevalence of *T. solium* taeniasis at the outset of an intervention, the size of the population that would be affected by the intervention and the sensitivity and specificity of the tests available for the detection of *T. solium* taeniasis.

Little accurate information is available about the prevalence of *T. solium* taeniasis in *T. solium* endemic areas of the world because most of the available methods to diagnose *T. solium* taeniasis are lacking in either sensitivity or both sensitivity and specificity. It is considered that the prevalence of *T. solium* taeniasis is commonly 1--2% of the population in many endemic regions [2](#pim12291-bib-0002){ref-type="ref"} although substantially higher rates have been reported for some areas [38](#pim12291-bib-0038){ref-type="ref"}, [39](#pim12291-bib-0039){ref-type="ref"}.

Direct assessment of taeniasis cases {#pim12291-sec-0007}
------------------------------------

One option for monitoring *T. solium* interventions is to determine the number of patients with *T. solium* taeniasis in the community following mass treatment with taeniacide. This could be undertaken even if treatment of taeniasis were not a formal component of an intervention, for example in the case where intervention was undertaken by public education alone or by interventions in pigs alone. Species‐specific identification of *T. solium* tapeworms would need to be carried out on worms voided by taeniasis carriers after treatment. A systematic collection scheme would be required to collect the worms, and a post‐treatment screen of stools, after mass treatment; otherwise, only a very small proportion of worms would be likely to be recovered.

Microscopic examination of faeces for *Taenia* eggs {#pim12291-sec-0008}
---------------------------------------------------

Microscopic examination of faecal samples for the presence of *Taenia* eggs has been used frequently in epidemiological studies of taeniasis [40](#pim12291-bib-0040){ref-type="ref"}, [41](#pim12291-bib-0041){ref-type="ref"}, [42](#pim12291-bib-0042){ref-type="ref"}. Irrespective of the particular technique used for the examination, it is known to be relatively insensitive [43](#pim12291-bib-0043){ref-type="ref"}, [44](#pim12291-bib-0044){ref-type="ref"}. Hall *et al*. [44](#pim12291-bib-0044){ref-type="ref"} were successful in diagnosing taeniasis due to *T. saginata* in 68% of confirmed cases, and Li *et al*. [40](#pim12291-bib-0040){ref-type="ref"} detected as few as 51·5% of cases of *T. solium* or *T. saginata* taeniasis by faecal microscopy. In settings of a low prevalence of infection, the cost/benefit ratio of this method of assessment would be low.

Coprology may identify the presence of a *Taenia* tapeworm; however, detection of eggs by microscopy will not itself determine which species is present because the eggs of different *Taenia* species are indistinguishable. Where mature proglottids are identified, they can be differentiated between *T. solium* and *T. saginata* on morphological criteria. Species‐specific diagnosis would be irrelevant if the purpose of the testing were to identify individuals so they could be treated because treatment would be warranted in any case. However, diagnosis to species level would certainly be necessary when data about taeniasis were to be used to monitor the outcomes of *T. solium* interventions; otherwise, infections with *T. saginata* or *T. asiatica* would confound the impact of control efforts specifically on *T. solium*.

Coproantigen detection assays {#pim12291-sec-0009}
-----------------------------

Parasite products other than eggs or proglottids are released with the faeces of *Taenia* carriers, and these can be detected in faecal samples using antibodies raised against excreted/secreted and/or adult somatic antigens. The tests are commonly known as coproantigen detection or CoproELISA. The first coproantigen test for taeniasis was devised by Allan *et al*. [10](#pim12291-bib-0010){ref-type="ref"}. It detected the presence of a *Taenia* sp. tapeworm and, although it was not species specific for *T. solium*, it had a higher sensitivity than faecal microscopy for diagnosis of taeniasis [45](#pim12291-bib-0045){ref-type="ref"}. Guezala *et al*. [46](#pim12291-bib-0046){ref-type="ref"} used antisera raised against *T. solium* adult excretory--secretory (ES) antigens together with a capture antibody raised against adult somatic antigens in a coproantigen ELISA and were able to differentiate *T. solium* taeniasis from *T. saginata*. Although reproduced by the authors, no subsequent publications refer to use of this species‐specific test and the reagents are no longer available (PS Craig, personal communication).

One area for concern regarding coproantigen tests is their reliance on polyclonal antisera. Different batches of polyclonal antisera are likely to have different titres and a different spectrum of antigen specificities. In replicating a published technique that relies on polyclonal antisera, it cannot be assumed that the replicated test would have an equivalent performance in regard to sensitivity and specificity for diagnosis of taeniasis to that described by other groups. Every new batch of reagent, and every new group that wished to adopt the method, would need to validate their reagents for sensitivity and specificity. Unfortunately, this has not occurred and coproantigen testing has been used by a number of researchers without providing adequate data to validate the performance of their particular variation of the test. All coproantigen tests rely on the use of specialized reagents and are currently not commercially available, limiting the use of coproantigen testing to research studies. Nevertheless, coproantigen testing has proved valuable in some studies. Bustos *et al*. [47](#pim12291-bib-0047){ref-type="ref"} identified patients with taeniasis in which treatment with niclosamide had failed, showing that 89% of successfully treated patients were coproantigen ELISA negative after 7 days, while 94·1% of treatment failures were coproantigen ELISA positive after 7 days. An interesting recent discovery has been the finding that the coproantigen ELISA test is not reliably positive until the tapeworm is, or nears being, gravid [48](#pim12291-bib-0048){ref-type="ref"}. The observation was made by Tembo and Craig [48](#pim12291-bib-0048){ref-type="ref"} while assessing the faeces of an individual after self‐infection with *T. saginata*.

Detection of specific antibody in serum {#pim12291-sec-0010}
---------------------------------------

Following the discovery in 1985 that animal definitive hosts of *Taenia* sp tapeworms induce specific antibodies that can be detected in serum [49](#pim12291-bib-0049){ref-type="ref"}, [50](#pim12291-bib-0050){ref-type="ref"}, it was found that the same was also the case for human taeniasis [51](#pim12291-bib-0051){ref-type="ref"}. The antigens that were found to be useful for serological diagnosis of *T. solium* taeniasis were ES products collected from adult tapeworms [51](#pim12291-bib-0051){ref-type="ref"}. Levine *et al*. [52](#pim12291-bib-0052){ref-type="ref"}, [53](#pim12291-bib-0053){ref-type="ref"} cloned and expressed two of the antigens, designated ES33 and ES38, and evaluated them for diagnosis of *T. solium* taeniasis. Both were very effective for diagnosis of *T. solium* taeniasis in an EITB format. The results were promising, with rES33 and rES38 having sensitivity/specificities of 98%/99% and 99%/97%, respectively. rES33 was better able to discriminate *T. solium* from *T. saginata* taeniasis [52](#pim12291-bib-0052){ref-type="ref"}. The antigens have subsequently been evaluated in studies investigating two user‐friendly test formats: multi‐antigen print immunoassay and a magnetic immunochromatographic test [54](#pim12291-bib-0054){ref-type="ref"}, [55](#pim12291-bib-0055){ref-type="ref"}. In these formats, some degree of cross‐reactivity was evident among sera from patients with cystic echinococcosis (5% cross‐reacting) and schistosomiasis (14--17%).

In circumstances where taeniasis was to be monitored as part of a *T. solium* control effort, and where the starting prevalence of taeniasis was not more than 2%, serological tests for taeniasis would necessarily be required to have a level of false‐positive reactivity in the target population of less than 2%; otherwise, the majority of the cases detected would be false positives. The serological test for taeniasis developed by Levine *et al*. [52](#pim12291-bib-0052){ref-type="ref"}, [53](#pim12291-bib-0053){ref-type="ref"} may be valuable as a screening assay in *T. solium* control programs, but positive cases would need to be verified by other means.

One area of concern in relation to using tests for the detection of specific circulating antibodies in patients with taeniasis is that the antibodies could possibly remain detectable for some time after individuals have been treated and were no longer infected. The persistence of specific antibodies to adult tapeworms following treatment for taeniasis has not been evaluated.

DNA‐based methods {#pim12291-sec-0011}
-----------------

Numerous methods have been developed which can identify, specifically, the presence of *T. solium* DNA using PCR‐based technologies. Many of these methods have been developed and applied to DNA purified directly from tapeworm or other parasite materials \[reviewed in [56](#pim12291-bib-0056){ref-type="ref"}\]. A smaller number of PCR‐based methods have been developed and validated for the detection of *T. solium* DNA with faecal material from patients with taeniasis who were subsequently proven to have been infected with *T. solium* [57](#pim12291-bib-0057){ref-type="ref"}, [58](#pim12291-bib-0058){ref-type="ref"}, [59](#pim12291-bib-0059){ref-type="ref"}, [60](#pim12291-bib-0060){ref-type="ref"}.

Where PCR‐based methods are used to differentiate *T. solium* proglottids from those of other *Taenia* species, they have distinct advantages over the use of morphological characteristics (number of uterine branches in proglottids or other characteristics) as the latter requires both specialist knowledge and skills. However, the more substantial value of PCR‐based methods is their potential to diagnose taeniasis using only a faecal sample.

PCR‐based methods are able to identify a higher proportion of taeniasis cases than are able to be diagnosed by microscopy alone, and a combination of both microscopy and coproPCR further improves diagnostic sensitivity (some proven egg‐positive cases are negative by coproPCR [59](#pim12291-bib-0059){ref-type="ref"}). Specificity for coproPCR is high with control faecal samples, including samples from patients with other parasitic infections, being almost always negative in coproPCR [57](#pim12291-bib-0057){ref-type="ref"}, [58](#pim12291-bib-0058){ref-type="ref"}, [59](#pim12291-bib-0059){ref-type="ref"}, [60](#pim12291-bib-0060){ref-type="ref"}, [61](#pim12291-bib-0061){ref-type="ref"}.

Yamasaki *et al*. [59](#pim12291-bib-0059){ref-type="ref"} established a multiplex PCR for differential diagnosis of taeniasis using amplification of the gene encoding cytochrome c oxidase subunit I (cox1). This approach has particular value in areas where *T. solium*,*T. saginata* and *T. asiatica* occur, as it allows differentiation between all three species. The method was assessed in a community level study in which 92 of 132 (69·7%) tapeworm carriers, confirmed by tapeworm or proglottid expulsion, were correctly diagnosed by coproPCR [40](#pim12291-bib-0040){ref-type="ref"}. Combined with microscopy, the positive detection rate increased to 102 of 132 (77·3%). Ten of the 132 confirmed patients with taeniasis that were egg positive by microscopy were negative using PCR.

Praet *et al*. [60](#pim12291-bib-0060){ref-type="ref"} developed a real‐time multiplex PCR for diagnosis of taeniasis which amplifies part of the internal transcribed spacer 1 of the ribosomal RNA. The protocol was applied to DNA extracts from 23 Ecuadorian stool samples which had previously been shown to be *Taenia* egg positive by microscopy. While all 23 faecal samples were PCR positive for the presence of *T. solium* and/or *T. saginata* DNA, it appears that the diagnoses were not confirmed to species level parasitologically. It is not clear what sensitivity the test would have for detecting taeniasis if it were applied to faecal samples that had not been preselected as being egg positive by microscopy.

Mayta *et al*. [57](#pim12291-bib-0057){ref-type="ref"} developed a nested PCR approach utilizing two rounds of PCR amplification of the Tso31 gene. Although the nested PCR approach imposes technical disadvantages, it has the advantage of having improved sensitivity. Mayta *et al*. [57](#pim12291-bib-0057){ref-type="ref"} were able to detect as few as 40 *T. solium* eggs per gram of faecal material, although it is unclear what quantum of eggs could be expected to be found per gram of a taeniasis patient\'s faeces. In 32 stool samples from *T. solium* carriers, 97% were found to be positive, and specificity was 100% when tested using 123 stool samples positive for other parasites including *T. saginata*,*Ascaris lumbricoides*,*Hymenolepis sp*., *Diphyllobothrium sp*. and hookworms. These are promising results, and the test warrants further validation.

Technical complexity and cost are disadvantages of the use of coproPCR as a mass screening tool for taeniasis in endemic areas. Other challenges include difficulties in the extraction of DNA from faeces and the presence of PCR enzyme inhibitors in faeces [62](#pim12291-bib-0062){ref-type="ref"}. Nkouawa *et al*. [58](#pim12291-bib-0058){ref-type="ref"} applied a DNA‐based test known as loop‐mediated isothermal amplification (LAMP) to address some of these challenges. The method provides species differentiation and does not require sophisticated equipment [63](#pim12291-bib-0063){ref-type="ref"}. Using the LAMP method and amplifying the cox1 gene, Nkouawa *et al*. [58](#pim12291-bib-0058){ref-type="ref"} were able to differentially identify *T. saginata*,*T. solium* and *T. asiatica* in 37 of 43 (86%) faecal samples from patients with parasitologically confirmed taeniasis. Data concerning specificity of the test are limited, although DNA prepared from parasite tissues of *A. lumbricoides*,*Enterobius vermicularis, Hymenolepis nana* and hookworms were shown to be negative. The method has been applied to a field survey, although it was only used on DNA extracted from proglottids rather than faecal samples [63](#pim12291-bib-0063){ref-type="ref"}. The test appeared to be effective even in very low technology conditions (no thermocycler) and warrants further investigation and validation.

In conclusion, the DNA‐based methodology developed by Mayta *et al*. [57](#pim12291-bib-0057){ref-type="ref"} provides the highest sensitivity and specificity of those methods that have been developed and validated using unselected faecal samples from parasitologically proven taeniasis carriers. While the method is technically challenging and could be expected to be relatively expensive to use, the reagents required are available worldwide and laboratories capable of undertaking PCR competently are present in most countries and in many regional areas.

Research/development needs {#pim12291-sec-0012}
--------------------------

Further and independent validation of the nested PCR method developed by Mayta *et al*. [57](#pim12291-bib-0057){ref-type="ref"}.Further and independent validation of the LAMP methodology described by Nkouawa *et al*. [58](#pim12291-bib-0058){ref-type="ref"}, especially validation of the test\'s potential to be effective when undertaken outside a sophisticated laboratory environment.

Porcine Cysticercosis {#pim12291-sec-0013}
=====================

While there is no doubt that eating infected pig meat is the major cause of *T. solium* taeniasis in humans, in some circumstances dogs may act as intermediate hosts for transmission of *T. solium* and may contribute to disease transmission where dog meat is consumed [64](#pim12291-bib-0064){ref-type="ref"}, [65](#pim12291-bib-0065){ref-type="ref"}. Reductions in porcine cysticercosis could be expected to be reflected in a reduced risk for human *T. solium* taeniasis and hence human cysticercosis. Monitoring porcine cysticercosis has been the most frequently used method for evaluation of *T. solium* control activities. It is easier and cheaper than testing humans as it does not involve the same level of expertise and/or ethical considerations. A major advantage of monitoring porcine cysticercosis over human infections is the much shorter life span of pigs, providing a time‐sensitive measure. A number of methods are available to detect porcine cysticercosis directly or indirectly; however, they vary greatly in their sensitivity, specificity and the quality of the evidence available to support diagnostic performance characteristics that have been claimed.

Direct detection of cysticerci {#pim12291-sec-0014}
------------------------------

Cysticerci can be detected in pigs either by palpation of the tongue or inspection of carcase tissues. Relatively few studies have undertaken tongue palpation before carcase examination, such that scientific data on specificity of tongue palpation are scarce; however, it has been reported to be high [66](#pim12291-bib-0066){ref-type="ref"}, [67](#pim12291-bib-0067){ref-type="ref"}. Tongue palpation is the simplest method for the detection of porcine cysticercosis. Estimates of the sensitivity of tongue palpation vary widely, from as low as 16% in some instances [66](#pim12291-bib-0066){ref-type="ref"} to 70% [67](#pim12291-bib-0067){ref-type="ref"}. Sciutto *et al*. [68](#pim12291-bib-0068){ref-type="ref"} did not undertake tongue inspection *per se*, but found only one of 18 naturally infected pigs that were subjected to full carcase dissection had any cysts in the tongue. Dorny *et al*. [69](#pim12291-bib-0069){ref-type="ref"} failed to identify infection by tongue palpation in any of 10 pigs lightly infected with *T. solium* (\<100 cysticerci) and detected infection in only five of 14 more heavily infected animals.

In pigs, *T. solium* encysts almost exclusively in the striated muscles and neural tissue [66](#pim12291-bib-0066){ref-type="ref"}. The definitive method for assessing the presence of cysticerci in pigs is by examination of carcase meat. Routine meat inspection as conducted in slaughterhouses is an insensitive procedure; as few as 38% of pigs infected with cysticerci were identified in Zambia [66](#pim12291-bib-0066){ref-type="ref"} by meat inspection, even though the inspection procedure that was employed included both a rigorous examination of the carcase as well as incisions in the external and internal masseters, heart, triceps and shoulder. Boa *et al*. [70](#pim12291-bib-0070){ref-type="ref"} determined that only 10·6% of *T. solium* cysts that were present in pigs could be identified in the organs that were examined at meat inspection.

Manual slicing of all carcase meat, and the brain, at approximately 3‐ to 5‐mm intervals will identify pigs with even very light *T. solium* infections. It is impossible to know the actual sensitivity of full carcase dissection and meat slicing, but it is likely to be close to 100%. The major disadvantage of carcase dissection is the cost, both for purchase of the pigs themselves as well as the skilled staff time required to carry out the examinations. An alternative to full carcase dissection can be dissection of some proportion of the meat. Simple probability would dictate that some lightly infected carcases would not be identified. Vargas Mendez *et al*. [71](#pim12291-bib-0071){ref-type="ref"} found no difference in *T. solium* encystation rates between the left and right side of pig carcases. Examination of half, or even a lesser proportion of the carcase, would enhance the feasibility of carcase examination for determining the prevalence of porcine cysticercosis in comparison to full carcase dissection.

A number of studies have investigated the distribution of *T. solium* cysticerci in naturally or experimentally infected pigs [68](#pim12291-bib-0068){ref-type="ref"}, [70](#pim12291-bib-0070){ref-type="ref"}, [71](#pim12291-bib-0071){ref-type="ref"}, [72](#pim12291-bib-0072){ref-type="ref"}, [73](#pim12291-bib-0073){ref-type="ref"}. Sites at which cysts are more commonly located, or predilection sites, include the masseter muscles, pterygoid, tongue, heart and triceps. Sciutto *et al*. [68](#pim12291-bib-0068){ref-type="ref"} found that 29 of 41 (71%) pigs experimentally infected with *T. solium* had cysts in the tongue (detected by slicing). However until recently, all publications describing the distribution of cysts in naturally infected animals have utilized pigs that were preselected as being infected with *T. solium* by tongue inspection. This is likely to have biased the sampling in favour of more heavily infected animals. Lightowlers *et al*. [74](#pim12291-bib-0074){ref-type="ref"} analysed the *T. solium* cyst distribution data from extensive necropsy examinations undertaken on 209 unselected pigs obtained from rural regions in which *T. solium* was endemic. These pigs were control animals involved in TSOL18 vaccine field trials undertaken in Cameroon (102 pigs) [14](#pim12291-bib-0014){ref-type="ref"} and Peru (107 pigs) [75](#pim12291-bib-0075){ref-type="ref"}. Of the animals that were detected as having *T. solium* infection (38 were infected), 81% were found to have cysts when only the heart, tongue and masticatory muscles were dissected. These data indicate that porcine cysticercosis can be diagnosed specifically and with a relatively high sensitivity by dissection of a limited but specific proportion of the muscle tissue. The proportion of infected pigs that were found to have cysts detected in the selected muscle sites was higher in animals having a heavier overall burden of infection. All the infected animals not found to have any cysts in the heart, tongue or masticatory muscles had relatively light infections (\<50 cysts, mean = 15, median = 7). Whether the value of partial carcase dissection for diagnosis of porcine cysticercosis would be affected following implementation of control measures for *T. solium*, would depend on the effect that the intervention had on the average burden of infection in infected pigs. Considerable evidence indicates that much of the transmission of *T. solium* to pigs occurs focally near the residence of *T. solium* patients with taeniasis [76](#pim12291-bib-0076){ref-type="ref"}, [77](#pim12291-bib-0077){ref-type="ref"}, although not all studies have supported this conclusion [78](#pim12291-bib-0078){ref-type="ref"}. Should this be the case, changes in the prevalence of taeniasis might be expected to affect the incidence of porcine cysticercosis, but not necessarily the burden of parasites in infected animals.

Serological tests {#pim12291-sec-0015}
-----------------

By far the simplest and least expensive method to diagnose porcine cysticercosis would be serology. Several tests have been developed and applied in many published studies on *T. solium* epidemiology or for assessment of *T. solium* control activities. Commercial kits are available for the detection of *T. solium* circulating antigens or anti‐*T. solium* antibodies in pigs. The available circulating antigen detection test is the same as that used for cysticercosis in humans. Purchase costs for the kit would entail a cost of €3·15 or USD 3·5/duplicate test. Quoted purchase costs for commercial antibody detection tests vary from USD 5--21 per test. While there is good evidence available to support the sensitivity of some tests, none have reported satisfactory evidence to substantiate claims concerning specificity.

Most of the serological tests that have been applied to porcine cysticercosis were developed initially for diagnosis of human cysticercosis. Some tests have been considered to be highly specific for *T. solium* cysticercosis, and the evidence to support the tests' specificity in humans appears to be solid. However, pigs are known to be infected with, and are likely to be exposed to many more species of taeniid cestode parasite than are humans, due to their foraging habit. For this reason, the potential for nonspecific positive serological reactions in porcine *T. solium* serology is greater than in human cysticercosis serology. Coprophagia by pigs is well recognized, both in relation to human faeces and the faeces of other animals [79](#pim12291-bib-0079){ref-type="ref"}, [80](#pim12291-bib-0080){ref-type="ref"}, [81](#pim12291-bib-0081){ref-type="ref"}. In rural areas, dogs and other carnivores are frequently infected with *Taenia* species tapeworms, including in regions where *T. solium* is prevalent [82](#pim12291-bib-0082){ref-type="ref"}, [83](#pim12291-bib-0083){ref-type="ref"}, [84](#pim12291-bib-0084){ref-type="ref"}, [85](#pim12291-bib-0085){ref-type="ref"}. One of these species is known to infect pigs with viable cysticerci (*T. hydatigena*); however, there is potential for eggs of the other *Taenia* species to hatch if ingested by pigs, for the oncospheres to penetrate and transiently invade the tissues, possibly remaining for long enough to cause a transient antibody response or the presence of circulating antigen that could be detected by serological tests used for porcine cysticercosis.

It has been known for some time that many serologically positive pigs are found to have no cysts when necropsied [68](#pim12291-bib-0068){ref-type="ref"}, [86](#pim12291-bib-0086){ref-type="ref"}, [87](#pim12291-bib-0087){ref-type="ref"}, [88](#pim12291-bib-0088){ref-type="ref"}. More recent and comprehensive data have confirmed that the great majority of rural pigs that are serologically positive for porcine cysticercosis are found to have no cysticerci at necropsy [36](#pim12291-bib-0036){ref-type="ref"}, [89](#pim12291-bib-0089){ref-type="ref"}, [90](#pim12291-bib-0090){ref-type="ref"}. In studies where sequential serum samples have been obtained from pigs in *T. solium* endemic rural areas prior to them being necropsied and found to have no cysts, the animals were commonly shown to seroconvert from negative to positive and back to negative [36](#pim12291-bib-0036){ref-type="ref"}, [90](#pim12291-bib-0090){ref-type="ref"}.

It is possible that false‐positive/transient positive reactions in serological tests for porcine cysticercosis could be due to exposure of the animals to *T. solium* eggs which did not lead to the establishment of cysticerci that could be found at necropsy. In the case of tests known to cross‐react with *T. hydatigena*, an equally valid argument could be made to suggest that the transient positives were due to exposure to that parasite. *T. hydatigena* is known to be highly prevalent in some areas of Africa where *T. solium* is also endemic [91](#pim12291-bib-0091){ref-type="ref"}. In addition, no assessment has been made of the potential for cross‐reactivity in tests for porcine cysticercosis due to exposure to *T. saginata*. *T. saginata* is known to be capable of establishing viable cysticerci in the liver of pigs following experimental infection [92](#pim12291-bib-0092){ref-type="ref"}. *T. solium* and *T. saginata* are commonly co‐endemic. In Africa, even in areas where *T. solium* is highly prevalent and beef is rarely eaten such as the eastern Province of Zambia [60](#pim12291-bib-0060){ref-type="ref"}, *T. saginata* prevalence may contribute as much as 14% of patients with taeniasis. In other regions of Africa, such as in the Dodoma region of Tanzania, the prevalence of *T. saginata* taeniasis is substantially higher than *T. solium* [93](#pim12291-bib-0093){ref-type="ref"}. It seems unlikely that infections with *T. saginata* occur commonly in pig livers. Few publications have described examination of the livers of pigs from *T. solium* endemic areas, but those that have, did not identify cysticerci in the liver [70](#pim12291-bib-0070){ref-type="ref"}. Nevertheless, the common occurrence of human taeniasis due to *T. saginata* in many areas where *T. solium* also occurs suggests that pigs have ample opportunity to be exposed to *T. saginata* eggs, in some situations more frequently than they are exposed to *T. solium*. Transient positive reactivity in serological tests for porcine cysticercosis could be partially or entirely due to exposure to *T. saginata*.

Pigs experimentally infected with *T. asiatica* show seroconversion within one week of infection in one antigen ELISA test commonly used for *T. solium* diagnosis [37](#pim12291-bib-0037){ref-type="ref"}. Seroconversion occurs long before the development of mature cysticerci, emphasizing the potential for exposure to *T. saginata* to lead to false‐positive reactions in serological tests for porcine cysticercosis. Pigs exposed to *T. asiatica* are also positive in the EITB assay [26](#pim12291-bib-0026){ref-type="ref"} that has been used frequently for diagnosis of both porcine and human cysticercosis.

Until data are available about serological responses in pigs following exposure to a variety of *Taenia* species, particularly *T. hydatigena* and *T. saginata*, none of the tests currently being employed can be considered to have been adequately assessed for specificity. Data published to date using porcine cysticercosis serology need to be interpreted with caution. Nevertheless, while the specificity of both EITB and antigen ELISA tests for porcine cysticercosis require further evaluation or improvement, both tests have a relatively high sensitivity for the detection of infection in most infected pigs. Hence, the tests have potential value in screening and selecting animals for necropsy. In this way, many uninfected animals could reasonably be excluded from requiring necropsy.

Research/development needs {#pim12291-sec-0016}
--------------------------

Further evidence is required concerning the specificity of all serological methods that are currently used for porcine cysticercosis.Improvement in the specificity of the antigen ELISA, certainly in relation to cross‐reactivity with *T. hydatigena*, but possibly also in relation to other possible causes of nonspecific reactions.Further validation of the sensitivity of examination of only a small part of pig carcases to achieve a relatively high sensitivity for diagnosis of infection in unselected, naturally infected pigs.

Influence of Sample Size on Monitoring *Taenia solium* Interventions {#pim12291-sec-0017}
====================================================================

Comments have been made above about the impact that a low overall prevalence of human taeniasis or cysticercosis would have on sample size requirements if these measures were used to evaluate the outcomes of *T. solium* control initiatives. While it would be important, and difficult, to minimize sample biasing while attempting to quantify the prevalence of taeniasis or cysticercosis, it is possible to determine the sample sizes that would be required to be evaluated assuming that sample bias could be avoided. Figure [1](#pim12291-fig-0001){ref-type="fig"} illustrates the number of observations that would be required to be made both at the start and at the end of an intervention period in order to detect an 80% decrease in infection prevalence with a type I error of 5% and a power of 80%. Where the prevalence of a particular assessment measure was relatively high at the beginning of an intervention, a relatively small number of samples would be required to be taken to detect a significant change due to intervention activities. While the precise numbers illustrated in Figure [1](#pim12291-fig-0001){ref-type="fig"} may differ slightly according to the particular assumptions used in the analyses, an example obtained using Fisher\'s exact test indicates that where there was a 25% prevalence of pig cysticercosis, the number of samples required to be able to detect at least an 80% decrease in porcine cysticercosis would be 55, taken at both the start and the end of the intervention. However, where the prevalence of the measure being evaluated was rare, for example a 2% prevalence of taeniasis, samples of 767 at both the start and end of an intervention would be required to detect an 80% decline over the period of the intervention.

![Number of observations required at the start and at the end of an intervention period in order to detect an 80% decrease in prevalence with a type I error of 5% and a power of 80% (Fisher\'s exact test, two sided). The numbers of observations are shown for each prevalence value plotted.](PIM-38-158-g001){#pim12291-fig-0001}

Suggestions for Monitoring Future *Taenia Solium* Control Initiatives {#pim12291-sec-0018}
=====================================================================

Based on the currently available data, and for the reasons elaborated above, the following suggestions are made about the most effective and appropriate methods that can be used for monitoring future *T. solium* control initiatives.

Human cysticercosis {#pim12291-sec-0019}
-------------------

Assessment of human cysticercosis levels as part of a *T. solium* control initiative would only be recommended where the sample size that could be evaluated was commensurate with obtaining statistically significant results.The use of serological tests which simply determine seroconversion cannot be recommended to evaluate control interventions until further data are available to confirm that transient serologically positive responses are uniquely due to exposure to *T. solium* and not some other cause. Measurements of prevalence using serological methods cannot be recommended because of the persistence of positive reactions in cysticercotic patients over the period of the intervention. Measures of incidence could be used, as determined by either EITB or antigen ELISA, provided the new cases were shown to remain persistently positive (i.e. are likely cases of actual infection).

Taeniasis {#pim12291-sec-0020}
---------

Assessment of taeniasis levels as part of a *T. solium* control initiative would only be recommended where the sample size that could be evaluated was commensurate with obtaining statistically significant results.The most effective and suggested method for species‐specific detection of human *T. solium* taeniasis is the nested PCR method developed by Mayta *et al*. [57](#pim12291-bib-0057){ref-type="ref"}.

Porcine cysticercosis {#pim12291-sec-0021}
---------------------

Serological methods cannot be recommended for porcine cysticercosis because none of the methods available has been adequately assessed for specificity. Due to their high sensitivity for detecting porcine cysticercosis, serological methods could be used as a pre‐necropsy screen so as to eliminate the need to undertake necropsy on uninfected animals.Porcine cysticercosis can only be adequately assessed by slicing carcase meat at necropsy. Thorough slicing of the heart, tongue and masticatory muscles is sufficient to detect 80% of naturally infected pigs and, where resources would not allow examination of more or all carcase meat and brain, assessment of the heart, tongue and masticatory muscles alone is suggested for diagnosis of porcine cysticercosis.
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